Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.10.0.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Total New Residential Stockholders’ Equity
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Equity, beginning balance (in shares) at Dec. 31, 2016   250,773,117          
Equity, beginning balance at Dec. 31, 2016 $ 3,468,177 $ 2,507 $ 2,920,730 $ 210,500 $ 126,363 $ 3,260,100 $ 208,077
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared (301,196)     (301,196)   (301,196)  
Capital contributions 0           0
Capital distributions (45,374)           (45,374)
Issuance of common stock (in shares)   56,545,787          
Issuance of common stock 834,529 $ 566 833,963     834,529  
Other dilution 625   625     625  
Director share grants (in shares)   42,405          
Director share grants 699 $ 1 698     699 0
Comprehensive income (loss)              
Net income (loss) 474,561     443,110   443,110 31,451
Net unrealized gain (loss) on securities 201,960       201,960 201,960  
Reclassification of net realized (gain) loss on securities into earnings (15,023)       (15,023) (15,023)  
Total comprehensive income (loss) 661,498         630,047 31,451
Equity, ending balance (in shares) at Jun. 30, 2017   307,361,309          
Equity, ending balance at Jun. 30, 2017 4,618,958 $ 3,074 3,756,016 352,414 313,300 4,424,804 194,154
Equity, beginning balance (in shares) at Dec. 31, 2017   307,361,309          
Equity, beginning balance at Dec. 31, 2017 4,796,162 $ 3,074 3,763,188 559,476 364,467 4,690,205 105,957
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared (337,999)     (337,999)   (337,999)  
Capital contributions 0           0
Capital distributions (37,015)           (37,015)
Issuance of common stock (in shares)   28,750,000          
Issuance of common stock $ 482,253 $ 288 481,965     482,253  
Options exercise (in shares) 15,803,216 3,694,228          
Option exercise $ 0 $ 36 (36)     0  
Director share grants (in shares)   57,231.5688073394          
Director share grants 1,019 $ 1 1,018     1,019 0
Comprehensive income (loss)              
Net income (loss) 800,200     779,011   779,011 21,189
Net unrealized gain (loss) on securities 37,045       37,045 37,045  
Reclassification of net realized (gain) loss on securities into earnings 57,259       57,259 57,259  
Total comprehensive income (loss) 894,504         873,315 21,189
Equity, ending balance (in shares) at Jun. 30, 2018   339,862,769          
Equity, ending balance at Jun. 30, 2018 $ 5,798,924 $ 3,399 $ 4,246,135 $ 1,000,488 $ 458,771 $ 5,708,793 $ 90,131